A narrative review of global inequities in access to uterine artery embolisation
Abstract
Uterine fibroids are the most common benign tumour of the female reproductive tract. For decades, surgery has been the standard treatment for symptomatic fibroids. However, minimally invasive options such as Uterine Artery Embolisation (UAE) have now emerged as a less invasive, but equally effective treatment. Despite this, access to UAE remains uneven worldwide. This cross-section from ten countries representing all inhabited continents across the globe, highlights several challenges that still exist, despite the abundance of evidence to support the long-term quality of life improvements for women treated with UAE. This narrative review considers enabling factors as well as barriers to treatment in each region, putting forward local strategies to improve access to UAE moving forward.
Read the paper
Related studies
- Understanding the factors influencing fall armyworm (Spodoptera frugiperda J.E. Smith) damage in African smallholder maize fields and quantifying its impact on yield. A case study in Eastern Zimbabwe
- Alarming situation of emerging H5 and H7 avian influenza and effective control strategies
- Livestock and food security: vulnerability to population growth and climate change
- Atmosphere–ocean oxygen and productivity dynamics during early animal radiations
- Characterization of the global distribution and diversified plasmid reservoirs of the colistin resistance gene mcr-9
- The global seroprevalence of Toxoplasma gondii in pigs: A systematic review and meta-analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.